Stock Track | Abivax S.A. Soars 12.18% in Pre-Market on Eli Lilly Takeover Bid Speculation

Stock Track2025-12-22

Abivax S.A. (ABVX) surged 12.18% in pre-market trading on Monday, following media reports of a potential takeover bid by pharmaceutical giant Eli Lilly.

French outlet La Lettre reported that Eli Lilly met with France’s Treasury in early December to discuss regulatory approval for a potential acquisition of the biotech firm. While Reuters could not immediately confirm the report, traders noted heightened speculation about a deal between the two companies. Abivax declined to comment on the rumors.

One trader suggested that if the meeting with the French Treasury did occur, it could indicate a price agreement between Eli Lilly and Abivax has been reached in principle. This speculation has driven significant investor interest in Abivax shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1125577838?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-22 17:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125577838","market":"sg","top_or_hot":-1,"title":"Stock Track | Abivax S.A. Soars 12.18% in Pre-Market on Eli Lilly Takeover Bid Speculation","media":"Stock Track","content":"<p>Abivax S.A. (ABVX) surged 12.18% in pre-market trading on Monday, following media reports of a potential takeover bid by pharmaceutical giant Eli Lilly.</p><p>French outlet La Lettre reported that Eli Lilly met with France’s Treasury in early December to discuss regulatory approval for a potential acquisition of the biotech firm. While Reuters could not immediately confirm the report, traders noted heightened speculation about a deal between the two companies. Abivax declined to comment on the rumors.</p><p>One trader suggested that if the meeting with the French Treasury did occur, it could indicate a price agreement between Eli Lilly and Abivax has been reached in principle. This speculation has driven significant investor interest in Abivax shares.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Abivax S.A. Soars 12.18% in Pre-Market on Eli Lilly Takeover Bid Speculation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Abivax S.A. Soars 12.18% in Pre-Market on Eli Lilly Takeover Bid Speculation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-12-22 17:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Abivax S.A. (ABVX) surged 12.18% in pre-market trading on Monday, following media reports of a potential takeover bid by pharmaceutical giant Eli Lilly.</p><p>French outlet La Lettre reported that Eli Lilly met with France’s Treasury in early December to discuss regulatory approval for a potential acquisition of the biotech firm. While Reuters could not immediately confirm the report, traders noted heightened speculation about a deal between the two companies. Abivax declined to comment on the rumors.</p><p>One trader suggested that if the meeting with the French Treasury did occur, it could indicate a price agreement between Eli Lilly and Abivax has been reached in principle. This speculation has driven significant investor interest in Abivax shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABVX","symbol_name":"Abivax S.A.","start_time":0,"source_url":"","article_id":"1125577838","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125577838","pubTimestamp":1766394625,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Abivax S.A. (ABVX) surged 12.18% in pre-market trading on Monday, following media reports of a potential takeover bid by pharmaceutical giant Eli Lilly.French outlet La Lettre reported that Eli Lilly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ABVX":"Abivax S.A."},"translate_title":"个股追踪|Abivax S.A.盘前大涨12.18%因礼来收购要约猜测","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABVX":1},"content_text":"Abivax S.A. (ABVX) surged 12.18% in pre-market trading on Monday, following media reports of a potential takeover bid by pharmaceutical giant Eli Lilly.French outlet La Lettre reported that Eli Lilly met with France’s Treasury in early December to discuss regulatory approval for a potential acquisition of the biotech firm. While Reuters could not immediately confirm the report, traders noted heightened speculation about a deal between the two companies. Abivax declined to comment on the rumors.One trader suggested that if the meeting with the French Treasury did occur, it could indicate a price agreement between Eli Lilly and Abivax has been reached in principle. This speculation has driven significant investor interest in Abivax shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1125577838","isCrawlerRequest":true}